This invention relates to 3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles of the formula I
where R₁ and R₂ are each independently hydrogen or loweralkyl or R₁ and R₂ taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R₃ ad R₄ are independently hydrogen or loweralkyl or R₃ and R₄ taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane or cycloheptane ring; R₅ is hydrogen, loweralkyl, alkanoyl or aroyl; X is halogen, loweralkyl or alkoxy; m is an integer of 0 to 3, the pharmaceutically acceptable acid addition salts thereof and where applicable, the optical, geometrical and stereoisomers and racemic mixtures thereof. The compounds of this invention are useful as antipsychotic agents.
本发明涉及式 I 的 3-[1-
噻唑烷基丁基-4-
哌嗪基]-1H-
吲唑
其中 R₁ 和 R₂ 各自独立地为氢或低级烷基,或 R₁ 和 R₂ 与它们所连接的碳原子一起形成
环戊烷、
环己烷或
环庚烷环;R₃ 和 R₄ 独立地为氢或低级烷基,或 R₃ 和 R₄ 与它们所连接的碳原子一起形成
环戊烷、
环己烷或
环庚烷环;R₅是氢、低级烷基、烷酰基或芳基;X 是卤素、低级烷基或烷氧基;m 是 0 至 3 的整数,其药学上可接受的酸加成盐,以及(如适用)其光学、几何和立体异构体及外消旋混合物。本发明的化合物可用作
抗精神病药物。